Literature DB >> 16234532

Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.

Richard Schwab1, Ferenc Pinter, Judit Moldavy, Judi Papay, Janos Strausz, Laszlo Kopper, Gyorgy Keri, Akos Pap, Istvan Petak, Karoly Oreskovich, Laszlo Mangel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16234532     DOI： 10.1200/JCO.2005.02.4760

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

Authors:  Ferenc Pinter; Judit Papay; Andrea Almasi; Zoltan Sapi; Edit Szabo; Melinda Kanya; Anna Tamasi; Balazs Jori; Edit Varkondi; Judit Moldvay; Klara Szondy; Gyorgy Keri; Massimo Dominici; Pierfranco Conte; Sandor Eckhardt; Laszlo Kopper; Richard Schwab; Istvan Petak
Journal:  J Mol Diagn       Date:  2008-02-07       Impact factor: 5.568

2.  Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas.

Authors:  Zhiyong Liang; Jing Zhang; Xuan Zeng; Jie Gao; Shafei Wu; Tonghua Liu
Journal:  BMC Cancer       Date:  2010-07-19       Impact factor: 4.430

3.  HeurAA: accurate and fast detection of genetic variations with a novel heuristic amplicon aligner program for next generation sequencing.

Authors:  Lőrinc S Pongor; Ferenc Pintér; István Peták
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.